medigraphic.com
Órgano oficial de la Sociedad Mexicana de Cirugía Dermatológica y Oncológica, AC

2008, Número 1

<< Anterior Siguiente >>

Dermatología Cosmética, Médica y Quirúrgica 2008; 6 (1)


Cosmecéuticos: ¿mito o realidad?

Guzmán SDA, González TYS, Alfaro AN

Idioma: Español
Referencias bibliográficas: 31
Paginas: 41-48
Archivo PDF: 152.09 Kb.


RESUMEN

Los cosmecéuticos son sustancias que, aplicadas localmente, producen un efecto rejuvenecedor en la piel.
Existen múltiples cosmecéuticos en el mercado, sin embargo, son pocos los que poseen fundamento científico para su uso.
En este artículo se define el concepto de cosmecéuticos, se mencionan los que se usan actualmente y que han sido estudiados de manera científica, su mecanismo de acción y sus efectos adversos. Estas sustancias mejoran de 43 a 85% la apariencia de la piel.
También incluimos un análisis comparativo de los diferentes cosmecéuticos y relacionamos su efectividad rejuvenecedora. Por último, mencionamos que estas sustancias se deben utilizar en forma conjunta con otro tipo de tratamientos rejuvenecedores (quirúrgicos y no quirúrgicos).


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Millikan, L., “Cosmetology, cosmetics, cosmecueticals: definitions and regulations”, Clinics in Dermatol. 2001; 19: 371-374.

  2. Draelos, Z., “The future of cosmeceuticals: an interview with Albert Kligman, MD, PhD”, Dermatol Surg. 2005; 31 (7): 890-1.

  3. Jenkins, G., “Molecular mechanisms of skin ageing”, Mechanisms of Ageing and Development. 2002; 123: 801-810.

  4. Rokhsar, C., S. Lee y R. E. Fitzpatrick, “Review of photorejuvenation: devices, cosmeceuticals or both?”, Dermatol. Surg. 2005; 31, 9 (2): 1166-1178.

  5. Sano, T., T. Kume, T. Fujimura et al., “The formation of wrinkles cau sed by transition of keratin intermidiate filaments after repetitive UVB sun exposure”, Arch. Dermatol. Res. 2005; 296: 359-365.

  6. Dufour, E. y N.-G. Larsson, “Understanding aging: revealing order out of chaos”, Biochim. Biophys. Acta. 2004; 1658 (1-2): 122-132.

  7. Partsch, B., W. Jochmann y H. Partsch, “Tobacco and skin”, Wien Med. Wochenschr. 1994; 144 (22-23): 565-568.

  8. Just, M., E. Monso, M. Ribera et al., “Relationships between lung function, smoking and morphology of dermal elastic fibres”, Exp. Dermatol. 2005; 14 (10): 744-751.

  9. Chuang, CH. y M. L. Hu, “Synergistic DNA damage and lipid peroxidation in cultured human white blood cells exposed to 4-(methylnitrosamino)- 1-(3-pyridyl)-1-butanone and ultraviolet A”, Environ. Mol. Mutagen. 2006; 47 (2): 73-81.

  10. Griffiths, C. E. M., A. N. Russman, G., Majmudar et al., “Restoration of collagen formation in photodamaged human skin by tretinoin”, N. Eng. J. Med. 1993; 329: 530-535.

  11. Andreano, J. M., W. F. Bergfeld y S. V. Medendorp, “Tretinoin emollient cream 0.01% for the treatment of photodamaged skin”, Cleve. Clin. J. Med. 1993; 60 (1): 49-55.

  12. Nyirady, J., W. Bergfeld, C. Ellis et al., “Tretinoin cream 0.02% for the treatment of photodamage facial skin: a review of 2 double blind clinical studies”, Cutis. 2001; 68: 135-142.

  13. Barel, A. O. et al., “Treatment for photodamaged skin with topical tretinoin: a blinded, vehicle controlled half-side study”, Nouvelles Dermatologiques, 1995; 14: 585-591.

  14. Kang, S. et al., “Long-term tretinoin efficacy for photodamaged facial skin”, Am. J. Clin. Dermatol. 2005; 6 (4): 245-253.

  15. Olsen, E., H. I. Katz, N. Levine et al., “Tretinoin emollient cream for photodamaged skin: results of 48 week, multicenter, double-blind studies”, J. Am. Acad. Dermatol. 1997; 37: 217-226.

  16. Samuel, M, Brooke RCC, Hollis S, Griffiths CEM. Interventions for photodamaged skin. Cochrane Database of Systematic Reviews 2005, Issue 1. Art. No.: CD001782.DOl: 10.1002/14651858.CD001782.pub2 (Pu - blicado en línea: 24 Enero 2005. Actualización 1 Noviembre 2004).

  17. Kang, S., J. J. Leyden, N. J. Lowe et al., “Tazarotene cream for the treatment for facial photodamage: A multicenter study, investigatormasked, randomized, vehicle-controlled, parallel comparison of 0.01%, 0.025%, 0.05% and 0.1% tazarotene creams with 0.05% tretinoin emollient cream applied once daily for 24 weeks”, Arch. Dermatol. 2001; 137: 1597-1604.

  18. Maddin, S., J. Lauharanta, P. Agache et al., “Isotretinoin improves the appearance of photodamaged skin: Results of a 36 week, multicenter, double-blind, placebo-controlled trial”, J. Am. Acad. Dermatol. 2000; 42: 56-63.

  19. Guzmán-Sánchez, D. A. y A. McMichael, “Topical uses of vitamin C”, Skin and Aging. 2006; 3: 53-59.

  20. 20.Trommer, H., R. Bottcher, C. Huschka et al., “Further investigations on the role of ascorbic acid in stratum corneum lipids models after UV exposure”, J. Pharm. Pharmacol. 2005; 57 (8): 963-972.

  21. Humbert, P. G., M. Haftek, P. Creidi et al., “Topical ascorbic acid on photoaged skin. Clinical, topographical and ultraestructural evaluation: double-blind study vs. Placebo”, Experimental Dermatology. 2003; 12: 237-244.

  22. Traikovich, S., “Use of topical ascorbic acid and Its effects on photodamaged skin topography”, Arch. Otolaryngol. Head Neck Surg. 1999; 125: 1091-1098.

  23. Yamamoto, Y., K. Uede, N. Yonei et al., “Effects of alpha-hydroxy acids on the human skin of Japanese subjects: the rationale for chemical peeling”, J. Dermatol. 2006; 33 (1): 16-22.

  24. Stilller, M. J., J. Bartolone, R. Stern et al., “Topical 8% glycolic acid and 8% L-lactic acid creams for the treatment of photodamaged skin”, Arch. Dermatol. 1996; 132: 631-636.

  25. Edison, B. et al., “A polyhydroxy acid skin care regimen provides antiaging effects comparable to an alpha-hydroxyacid regimen”, Cutis. 2004; 73 (2): 14-17.

  26. Lassus, A. et al., “The effect of Vivida cream as compared to placebo cream in the treatment of sun-damaged facial skin”, The J. Inter na - tional Medical Research. 1992; 20: 381-391.

  27. Eskelinen, A. y Santalahti, J., “Special natural cartilage polysaccharides for the treatment of sun-damaged skin in females”, The J. International Medical Research. 1992; 20: 99-105.

  28. Ehrlich, M. et al. “Improvement in the appearance of wrinkles with topical transforming growth factor beta(1) and l-ascorbic acid”, Dermatol. Surg. 2006; 32 (5): 618-625.

  29. 29.Gold, M. H., M. P. Goldman, J. Biron, “Efficacy of novel skin cream containing mixture of human growth factors and cytokines for skin rejuvenation”, J. Drugs. Dermatol. 2007; 6 (2): 197-201.

  30. Ardigò, M., I. Maliszewski, C. Cota, A. Scope, G. Sacerdoti, S. Gon - zález, E. Berardesca, “Preliminary evaluation of in vivo reflectance confocal microscopy features of Discoid lupus erythematosus”, Br. J. Dermatol. 2007; 156 (6): 1196-1203.

  31. Wilkin, J., M. Dahl, M. Detmar, L. Drake, M. H. Liang, R. Odom et al., “Standard grading system for rosacea: report of the National Rosacea Society Expert Committee on the classification and staging of rosacea”. J. Am. Acad. Dermatol. 2004; 50 (6): 907-912.




2020     |     www.medigraphic.com